Clinical and molecular implications of antipsychotics in MASLD Celina Gonzalez; Misael Uribe; Norberto C. Chavez-Tapia;

Metabolic dysfunction: The silenced connection with fatty liver disease Mariana M. Ramírez-Mejía; Xingshun Qi; Ludovico Abenavoli; Manuel Romero-Gómez; Mohammed Eslam; Nahum Méndez-Sánchez;

Genetic risk factors for MASLD/MASH and cardiovascular disease in elderly individuals Willy B. Theel; Vivian D. de Jong; Diederick E. Grobbee; J. Wouter Jukema; Stella Trompet; Manuel Castro Cabezas;